Genomic Profiling for NSCLC Improves Survival Outcomes With Modest Budget Impact

An increase in the use of comprehensive genomic profiling among patients with advanced non–small cell lung cancer (NSCLC) was associated with additional life-years gained and a low-cost budget impact. Increasing use of comprehensive genomic profiling (CGP) may lead to improved survival outcomes among patients with advanced non–small cell...